Quote:
Originally Posted by red-beard
I do wonder why it took two weeks each to approve Pfizer and Moderna.
|
https://www.biospace.com/article/why-is-the-fda-taking-so-long-to-review-a-covid-19-vaccine-/#:~:text=)%20News%20(942)-,Why%20is%20the%20FDA%20Taking%20So,Review%20a%20C OVID%2D19%20Vaccine%3F&text=According%20to%20the%20FDA%2C%20%E2%80%9CThis ,with%20the%20advisory%20committee%20members.%E2%8 0%9D
“This amount of time will allow the FDA to thoroughly evaluate the data and information submitted in the EUA request before the meeting and to be prepared for a robust public discussion with the advisory committee members.”
The thing that gets me about that statement is, it was my understanding that the FDA was "in the loop" through all trial phases. I don't know why they'd need additional time to review the data when they had been seeing the data in real time as part of the information sharing that was supposed to be involved with OWS.